Pregnancy and breastfeeding in inflammatory bowel disease

Digestion

Volumn 86, Issue SUPPL. 1, 2012, Pages 45-54

  Biedermann, Luc ^a   Rogler, Gerhard ^a,b   Vavricka, Stephan R ^a,c   Seibold, Frank ^d   Seirafi, Mariam ^e  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c Division of Gastroenterology and Hepatology   (Switzerland)

^d Spital Bern Tiefenau   (Switzerland)

^e GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Breastfeeding; Medical therapy benefits; Pregnancy

Indexed keywords

ACETYLSALICYLIC ACID; ADALIMUMAB; CYCLOSPORIN; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; SALAZOSULFAPYRIDINE; SULFAPYRIDINE; TACROLIMUS; THALIDOMIDE;

APPENDECTOMY; ARTICLE; BREAST FEEDING; COHORT ANALYSIS; COLON RESECTION; COLONOSCOPY; COLOSTOMY; CONCEPTION; ENDOSCOPY; ENTERITIS; EPISIOTOMY; ETHNICITY; FEMALE INFERTILITY; FETUS HYPOXIA; FETUS WASTAGE; HEREDITY; HIGH RISK PREGNANCY; HUMAN; ILEOSTOMY; LOW BIRTH WEIGHT; OLIGOSPERMIA; PREGNANCY; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; PROCTOCOLECTOMY; PROGNOSIS; PROSPECTIVE STUDY; REMISSION; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SECONDARY AMENORRHEA; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; SMALL FOR DATE INFANT; SMOKING; SMOKING CESSATION; SPERMATOZOON MOTILITY; TERATOGENICITY; THERAPEUTIC ABORTION; VAGINAL DELIVERY;

ANTI-INFLAMMATORY AGENTS; BREAST FEEDING; COLECTOMY; COMBINED MODALITY THERAPY; DELIVERY, OBSTETRIC; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFERTILITY, FEMALE; INFLAMMATORY BOWEL DISEASES; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RISK FACTORS;

EID: 84867564414     PISSN: 00122823     EISSN: 14219867     Source Type: Journal    
DOI: 10.1159/000341941     Document Type: Article

References (84)

1. Molodecky NA, Soon IS, Rabi DM, et al: Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142:46-54.
2. Munkholm P: Crohn's disease-occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bul l 1997; 44: 287-302.
3. Baiocco PJ, Korelitz BI: The influence of inflammatory bowel disease and its treatment on pregnancy and fetal outcome. J Clin Gastroenterol 1984; 6:211-216.
4. van Assche G, Dignass A, Reinisch W, et al: The second European evidence-based consensus on the diagnosis and management of Crohn's disease: special situations. J Crohn Colitis 2010; 4:63-101.
5. Livia Biancone, Pierre Michetti, Simon Travis, et al: European evidence-based consensus on the management of ulcerative colitis: special situations 2008; 2:63-92.
6. Beaulieu DB, Kane S: Inflammatory bowel disease in pregnancy. World J Gastroenterol 2011; 17:2696-2701.
7. Dubinsky M, Abraham B, Mahadevan U: Management of the pregnant IBD patient. Inflamm Bowel Dis 2008; 14:1736-1750.
8. Habal FM, Huang VW: Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient. Aliment Pharmacol Ther 2012; 35: 501-515.
9. Habal FM, Ravindran NC: Management of inflammatory bowel disease in the pregnant patient. World J Gastroenterol 2008; 14: 1326-1332.
10. Mottet C, Juillerat P, Pittet V, et al: Pregnancy and breastfeeding in patients with Crohn's disease. Digestion 2007; 76:149-160.
11. Bortoli A, Pedersen N, Duricova D, et al: Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther 2011; 34: 724-734.
12. Loftus EV Jr: Clinical epidemiology of inf lammator y bowel d isea se: incidence, prevalence, and environmental influences. Gastroenterology 2004; 126:1504-1517.
13. Orholm M, Fonager K, Sørensen HAT: Risk of ulcerative colitis and Crohn's disease among offspring of patients with chronic inflammatory bowel disease. Am J Gastroen-terol 1999; 94: 3236-3238.
14. Russell RK, Satsangi J: IBD: a family affair. Best Pract Res Clin Gastroenterol 2004; 18: 525-539.
15. Akolkar PN, Gulwani-Akolkar B, Heresbach D, et al: Differences in risk of Crohn's disease in offspring of mothers and fathers with inflammatory bowel disease. Am J Gastroen-terol 1997; 92: 2241-2244.
16. Orholm M, Munkholm P, Langholz E, et al: Familial occurrence of inflammatory bowel disease. N Engl J Med 1991; 324: 84-88.
17. Mahadevan U: Fertility and pregnancy in the patient with inflammatory bowel disease. Gut 2006; 55:1198-1206.
18. Bennett RA, Rubin PH, Present DH: Frequency of inflammatory bowel disease in offspring of couples both presenting with inflammatory bowel disease. Gastroenterolo-gy 1991; 100:1638-1643.
19. Mountifield R, Bampton P, Prosser R, et al: Fear and fertility in inf lammatory bowel disease: a mismatch of perception and reality affects family planning decisions. Inflamm Bowel Dis 2009; 15:720-725.
20. Willoughby CP, Truelove SC: Ulcerative colitis and pregnancy. Gut 1980; 21:469-474.
21. Hudson M, Flett G, Sinclair TS, et al: Fertility and pregnancy in inflammatory bowel disease. Int J Gy naecol Obstet 1997; 58: 229-237.
22. Khosla R, Willoughby CP, Jewell DP: Crohn's disease and pregnancy. Gut 1984; 25:52-56.
23. Heetun ZS, Byrnes C, Neary P, et al: Review article: Reproduction in the patient with inflammatory bowel disease. Aliment Pharmacol Ther 2007; 26: 513-533.
24. Olsen KO, Joelsson M, Laurberg S, et al: Fertility after ileal pouch-anal anastomosis in women with ulcerative colitis. Br J Surg 1999; 86:493-495.
25. Olsen KØ, Juul S, Bülow S, et al: Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003; 90:227-231.
26. Jones R: Treatment of irritable bowel syndrome in primary care. BMJ 2008; 337:a2213.
27. Cornish JA, Tan E, Singh B, et al: Female infertility following restorative proctocolecto-my. Colorectal Dis 2011; 13:e339-344.
28. Gorgun E, Remzi FH, Goldberg JM, et al: Fertility is reduced after restorative procto-colectomy with ileal pouch anal anastomosis: a study of 300 patients. Surgery 2004; 136: 795-803.
29. Lepistö A, Sarna S, Tiitinen A, et al: Female fertility and childbirth after ileal pouch-anal anastomosis for ulcerative colitis. Br J Surg 2007; 94: 478-482.
30. Bartels SA, Dhoore A, Cuesta MA, et al: Significantly increased pregnancy rates after laparoscopic restorative proctocolectomy: a cross-sectional study. Ann Surg 2012, E-pub ahead of print.
31. Levi AJ, Fisher AM, Hughes L, et al: Male infertility due to sulphasalazine. Lancet 1979; 2:276-278.
32. O'Moráin C, Smethurst P, Doré CJ, et al: Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984; 25: 1078-1084.
33. Zelissen PM, van Hattum J, Poen H, et al: Influence of salazosulphapyridine and 5-aminosalicylic acid on seminal qualities and male sex hormones. Scand J Gastroen-terol 1988; 23: 1100-1104.
34. van der Woude CJ, Kolacek S, Dotan I, et al: European evidenced-based consensus on reproduction in inflammatory bowel disease. J Crohn Colitis 2010; 4: 493-510.
35. Morales M, Berney T, Jenny A, et al: Crohn's disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000; 47:1595-1598.
36. Nielsen OH, Andreasson B, Bondesen S, et al: Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983; 18: 735-742.
37. Nielsen OH, Andreasson B, Bondesen S, et al: Pregnancy in Crohn's disease. Scand J Gastroenterol 1984; 19: 724-732.
38. Mountifield RE, Prosser R, Bampton P, et al: Pregnancy and IBD treatment: this challenging interplay from a patients' perspective. J Crohn Colitis 2010; 4:176-182.
39. Agret F, Cosnes J, Hassani Z, et al: Impact of pregnancy on the clinical activity of Crohn's disease. Aliment Pharmacol Ther 2005; 21: 509-513.
40. Castiglione F, Pignata S, Morace F, et al: Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 1996; 28: 199-204.
41. Riis L, Vind I, Politi P, et al: Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006; 101: 1539-1545.
42. Kane S, Kisiel J, Shih L, et al: HLA disparity determines disease activity through pregnancy in women with inflammatory bowel disease. Am J Gastroenterol 2004; 99: 1523-1526.
43. Fonager K, Sørensen HT, Olsen J, et al: Pregnancy outcome for women with Crohn's disease: a follow-up study based on linkage between national registries. Am J Gastroenter-ol 1998; 93: 2426-2430.
44. Nørgård B, Fonager K, Sørensen HT, et al: Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study. Am J Gastroenterol 2000; 95:3165-3170.
45. Kornfeld D, Cnattingius S, Ekbom A: Pregnancy outcomes in women with inflammatory bowel disease-a population-based cohort study. Am J Obstet Gynecol 1997; 177: 942-946.
46. Cornish J, Tan E, Teare J, et al: A meta-anal-ysis on the influence of inflammatory bowel disease on pregnancy. Gut 2007; 56: 830-837.
47. Katz JA, Antoni C, Keenan GF, et al: Outcome of pregnancy in women receiving inf-liximab for the treatment of Crohn's disease and rheumatoid arthritis. Am J Gastroenter-ol 2004; 99: 2385-2392.
48. Mahadevan U, Sandborn WJ, Li D, et al: Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterolog y 2007; 133: 1106-1112.
49. Stephansson O, Larsson H, Pedersen L, et al: Crohn's disease is a risk factor for preterm birth. Clin Gastroenterol Hepatol 2010; 8: 509-515.
50. Moser MAJ, Okun NB, Mayes DC, et al: Crohn's disease, pregnancy, and birth weight. Am J Gastroenterol 2000; 95: 1021-1026.
51. Ilnyckyji A, Blanchard JF, Rawsthorne P, et al: Perianal Crohn's disease and pregnancy: role of the mode of delivery. Am J Gastroen-terol 1999; 94: 3274-3278.
52. Brandt LJ, Estabrook SG, Reinus JF: Results of a survey to evaluate whether vaginal delivery and episiotomy lead to perineal involvement in women with Crohn's disease. Am J Gastroenterol 1995; 90: 1918-1922.
53. Cappell MS: Sedation and analgesia for gastrointestinal endoscopy during pregnancy: women's issues in gastrointestinal endosco-py. Gastrointest Endosc Clin North Am 2006; 16:1-31.
54. Visser BC, Glasgow RE, Mulvihill KK, et al: Safety and timing of nonobstetric abdominal surgery in pregnancy. Dig Surg 2001; 18: 409-417.
55. Kane S, Lemieux N: The role of breastfeeding in postpartum disease activity in women w ith inf lammator y bowel disease. Am J Gastroenterol 2005; 100:102-105.
56. Nørgård B, Pedersen L, Fonager K, et al: Aza-thioprine, mercaptopurine and birth outcome: a population-based cohort study. Aliment Pharmacol Ther 2003; 17:827-834.
57. Coelho J, Beaugerie L, Colombel JF, et al: Pregnancy outcome in patients with inflammatory bowel disease treated with thiopu-rines: cohort from the CESAME Study. Gut 2011; 60: 198-203.
58. Mahadevan U, Martin CF, Sandler RS, et al: 865 PIANO: a 1000 patient prospective registry of pregnancy outcomes in women with IBD exposed to immunomodulators and biologic therapy. Gastroenterology 2012; 142: 149.
59. Zelinkova Z, de Haar C, de Ridder L, et al: High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy. Aliment Pharmacol Ther 2011; 33:1053-1058.
60. Seirafi M, Treton X, Vroey B de, et al: Anti-TNF therapy and pregnancy in inflammatory bowel disease: a prospective cohort study from the GETAID. Gastroenterology 2011; 140: 175.
61. Schnitzler F, Fidder H, Ferrante M, et al: Outcome of pregnancy in women with inflammatory bowel disease treated with anti-tumor necrosis factor therapy. Inflamm Bowel Dis 2011; 17:1846-1854.
62. Lichtenstein GR, Feagan BG, Cohen RD, et al: Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006; 4: 621-630.
63. Rahimi R, Nikfar S, Rezaie A, et al: Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-ami-nosalicylic acid drugs: a meta-analysis. Re-prod Toxicol 2008; 25: 271-275.
64. Hernández-Díaz S, Mitchell AA, Kelley KE, et al: Medications as a potential source of exposure to phthalates in the U.S. population. Environ Health Perspect 2009; 117: 185-189.
65. Park-Wyllie L, Mazzotta P, Pastuszak A, et al: Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000; 62: 385-392.
66. Gur C, Diav-Citrin O, Shechtman S, et al: Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004; 18: 93-101.
67. Beaulieu DB, Ananthakrishnan AN, Issa M, et al: Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis 2009; 15:25-28.
68. Ost L: Prednisolone excretion in human milk. J Pediatr 1985; 106:1008-1011.
69. Francella A, Dyan A, Bodian C, et al: The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study. Gastroenterolo-g y 2003; 124: 9-17.
70. Goldstein LH, Dolinsky G, Greenberg R, et al: Pregnancy outcome of women exposed to azathioprine during pregnancy. Birth Defects Res Part A Clin Mol Teratol 2007; 79: 696-701.
71. Langagergaard V, Pedersen L, Gislum M, et al: Birth outcome in women treated with aza-thioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study. Aliment Pharmacol Ther 2007; 25:73-81.
72. Nørgård B, Pedersen L, Christensen LA, et al: Therapeutic drug use in women with Crohn's disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroen-terol 2007; 102:1406-1413.
73. Cleary BJ, Källén B: Early pregnancy azathi-oprine use and pregnancy outcomes. Birth Defects Res Part A Clin Mol Teratol 2009; 85: 647-654.
74. Shim L, Eslick GD, Simring AA, et al: The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohn Colitis 2011; 5:234-238.
75. Sau A, Clarke S, Bass J, et al: Azathioprine and breastfeeding-is it safe? Br J Obstet Gynaecol 2007; 114:498-501.
76. Christensen LA, Dahlerup JF, Nielsen MJ, et al: Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008; 28:1209-1213.
77. Angelberger S, Reinisch W, Messerschmidt A, et al: Long-term follow-up of babies exposed to azathioprine in utero and via breastfeeding. J Crohn Colitis 2011; 5: 95-100.
78. Cheent K, Nolan J, Shariq S, et al: Case report: fatal case of disseminated BCG infection in an infant born to a mother taking in-fliximab for Crohn's disease. J Crohn Colitis 2010; 4:603-605.
79. Bar Oz B, Hackman R, Einarson T, et al: Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 2001; 71: 1051-1055.
80. Vasiliauskas EA, Church JA, Silverman N, et al: Case report: evidence for transplacental transfer of maternally administered inflixi-mab to the newborn. Clin Gastroenterol Hepatol 2006; 4:1255-1258.
81. Jain AB, Reyes J, Marcos A, et al: Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years. Transplantation 2003; 76:827-832.
82. Baumgart DC, Sturm A, Wiedenmann B, et al: Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcer-ative colitis. Gut 2005; 54:1822-1823.
83. Gardiner SJ, Begg EJ: Breastfeeding during tacrolimus therapy. Obstet Gynecol 2006; 107:453-455.
84. Czeizel AE, Rockenbauer M: A population based case-control teratologic study of oral metronidazole treatment during pregnancy. Br J Obstet Gynaecol 1998; 105:322-327.